Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2021, IVT Network
Numbers are essential to validation, just as numbers are critical to much of human activity. Numbers represent the continuous variables that we use to describe the world. Numbers can be something directly observable, or they can be theoretical constructs, used as parameters within a model. While both play a part in ‘validation’, it is with the former that this article toys with. The issue at hand is with how much validation is required at the performance qualification stage for a given validation stage? This may be a cleaning cycle on a vessel or an autoclave load. How many times should such validation exercises be conducted in order to show that the results are reliable? While the number of runs should rest with the outcome of a risk assessment, it is generally the rule that the number of runs is seldom less than three. This begs two questions: why is three considered acceptable?, and is three enough? Before entering this debate it is interesting to consider what is so special about the number 3. After this, this article looks at the issue from the process validation perspective and the analytical assay perspective, concluding that three runs or assays is rarely enough. Moreover, with process validation greater weight should be put onto the lifecycle approach for trending and hence understanding process performance.
Toxicology in Vitro, 1995
With regard to the problems encountered and the experience gained in validation studies conducted in the past, suggestions have been made concerning criteria for the selection of the tests and laboratories to be included in a validation study, the selection and distribution of test chemicals, and procedures for the handling, analysis and interpretation of the resulting data. In particular, tests
AAPS PharmSciTech, 2015
AAPS PharmSciTech, 2016
The paper introduces evaluation methodologies and associated statistical approaches for process validation lifecycle Stage 3A. The assessment tools proposed can be applied to newly developed and launched small molecule as well as bio-pharma products, where substantial process and product knowledge has been gathered. The following elements may be included in Stage 3A: number of 3A batch determination; evaluation of critical material attributes, critical process parameters, critical quality attributes; in vivo in vitro correlation; estimation of inherent process variability (IPV) and PaCS index; process capability and quality dashboard (PCQd); and enhanced control strategy. US FDA guidance on Process Validation: General Principles and Practices, January 2011 encourages applying previous credible experience with suitably similar products and processes. A complete Stage 3A evaluation is a valuable resource for product development and future risk mitigation of similar products and proces...
International Journal of Advanced Research in Science, Communication and Technology
Each pharmaceutical industry's objective is to reliably and affordably produce goods with the necessary qualities and attributes. Method development is crucial for drug discovery, development, and evaluation in pharmaceutical formulations drug discovery, development, and evaluation in pharmaceutical formulations, method development is crucial. This review article's main goal was to examine how pharmaceutical manufacturing procedures are developed and validated from the beginning of formulation to the final commercial batch of product. The results must be trustworthy when analytical procedures are used to get high-quality results for pharmaceutical samples.A verification policy in the pharmaceutical business specifies how verification is carried out, and both the type of verification and the verification policy adhere to Good Manufacturing Practice (GMP) laws. The efficient running of pharmaceutical enterprises depends on validation. From raw ingredients to finished goods, st...
Bioprocess International, 2023
The 2011 process validation (PV) guidance document from the Food and Drug Administration (FDA) states, “The number of samples should be adequate to provide sufficient statistical confidence of quality both within a batch and between batches. The confidence level selected can be based on risk analysis as it relates to the particular attribute under examination.” [1] In alignment with the FDA’s expectations, this article details two statistical methodologies for calculating the number of process performance qualification (PPQ) runs, namely, the tolerance interval (TI) method and the process capability (PpK) method. Both methods are performed by applying the following steps in sequence to demonstrate that the PPQ results obtained have an acceptable statistical confidence: 1. Assess the risk of the attribute/parameter to be monitored. 2. Statistically assess the reliability for the sample size of data used to gain process knowledge. 3. Define the target statistical confidence and reliability based on a risk assessment matrix. 4. Compensate for the uncertainty of the limited sample size by replacing the sample mean and sample standard deviation using appropriate confidence intervals to model the data distribution at the desired confidence. 5. Estimate the risk of failure to meet predefined acceptable ranges based on the modeled data distribution. 6. Calculate the adequate number of PPQ runs based on the minimum sample size required to control the uncertainty on the estimated risk of failure. This article also details how to consider both inter- and intra-batch variability when calculating the number of PPQ runs. Although other statistical approaches, such as methods based on expected coverage, probability of batch success, and variability, have been reported for calculating the number of PPQ runs, these methods have limitations in either arbitrarily assigning risk ratings or not being driven by historical process knowledge gained. [2] Furthermore, this article provides a step-by-step procedure for calculating the number of PPQ runs using MS Excel as a tool with illustrative examples for both methods (PpK and TI) for easy adaptation and implementation by the reader.
Innovare Journal of Food Sciences, 2013
Journal of Chemometrics, 2010
Chemometrics and Intelligent Laboratory Systems, 2007
Accreditation and Quality Assurance, 2017
Ieromonah GHELASIE GHEORGHE - Mystagogia icoanei
Septuagint and Reception: Essays Prepared for the Association for the Study of the Septuagint in South Africa, ed. J. Cook, VTSup 127 (Leiden: Brill), 2009
Martial Arts as Embodied Knowledge: Asian Traditions in a Transnational World, 2011
Financing Development is Islam, Jeddah: Islamic …, 1996
Θεσσαλονικέων Πόλις, Μάρτιος 2020, 2020
Ludus Vitalis. Revista de Filosofía de las Ciencias de la Vida, 2024
Revista Suroeste, 2023
Hitit Üniversitesi Sosyal Bilimler Enstitüsü Dergisi, 2019
Corporate Ownership & Control, 2024
International Journal of Orthopaedics Sciences, 2021
NABS _ National Academy of Behavioral Science, 2024
Molecular pharmacology, 2003
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2015